An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

Mostrar otras versiones (1)

The emergence of the highly-transmissible B.1.1.529 Omicron variant of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for antibody countermeasure efficacy because of the number of mutations in the spike protein. Here, we tested a panel of anti-receptor binding domain mono...

Descripción completa

Detalles Bibliográficos
Autores principales: VanBlargan, Laura, Errico, John, Halfmann, Peter, Zost, Seth, Crowe, James, Purcell, Lisa, Kawaoka, Yoshihiro, Corti, Davide, Fremont, Daved, Diamond, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722605/
https://www.ncbi.nlm.nih.gov/pubmed/34981042
http://dx.doi.org/10.21203/rs.3.rs-1175516/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722605/
https://www.ncbi.nlm.nih.gov/pubmed/34981042
http://dx.doi.org/10.21203/rs.3.rs-1175516/v1

Ejemplares similares